ALS patients request more information about cognitive symptoms

@article{Wicks2008ALSPR,
  title={ALS patients request more information about cognitive symptoms},
  author={Paul Wicks and Jo Frost},
  journal={European Journal of Neurology},
  year={2008},
  volume={15}
}
  • P. Wicks, J. Frost
  • Published 1 May 2008
  • Medicine, Psychology
  • European Journal of Neurology
Background and purpose:  Once thought to impact only voluntary motor function, ALS/Motor neuron disease (MND) is now seen as a multi‐system disorder in which a minority of patients experience mild cognitive dysfunction or frontotemporal dementia. Despite clinical guidelines advocating supplying complete information to patients, educational materials on ALS often state that the mind is unaffected. We sought to establish how much patients and caregivers understand about ALS, what they have been… 

Reassessing received wisdom in ALS – pain is common when studied systematically

  • P. Wicks
  • Medicine, Psychology
    European journal of neurology
  • 2012
A systematic evaluation of pain is described, a previously under-recognized symptom in a well-characterized population with an age-matched healthy control group, and finds that most of the patients with ALS reported pain in the previous week, with 14% in pain rated as severe according to the Brief Pain Inventory.

Insight in ALS: Awareness of behavioral change in patients with and without FTD

  • S. WoolleyD. MooreJ. Katz
  • Psychology, Medicine
    Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases
  • 2010
Patients with ALS-FTD exhibit a profound lack of insight, which is not found in non-demented ALS patients, and patients without dementia have normal insight, although they report mild behavioral changes that might reflect a psychological response to the disease.

Cognitive impairment in patients with amyotrophic lateral sclerosis: a neuropsychological perspective

The multilayer importance of reliable identification of cognitive change in this disease, including implications for clinical work is highlighted, as well as the options and latest recommendations for neuropsychological evaluation of ALS patients’ cognitive changes in the clinical setting.

Reassessing received wisdom in ALS – pain

Reassessing received wisdom in ALS – pain is common when studied systematically Amyotrophic lateral sclerosis (ALS) is a neurodegen-erative disorder that presents many challenges for patients and

Cognitive impairment in amyotrophic lateral sclerosis

A comparison of estimates by different scores of emotional state and quality of life (the Hamilton depression scale, CNSLS, ALSAQ40) allows to conclude that CC had no influence on the emotional state of ALS patients and their totalquality of life.

ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS

Findings suggest that cognitive and behavioral change should be incorporated into ALS diagnostic criteria and should be included in future staging systems.

[Cognitive impairment in amyotrophic lateral sclerosis].

A comparison of estimates by different scores of emotional state and quality of life (the Hamilton depression scale, CNSLS, ALSAQ40) allows to conclude that CC had no influence on the emotional state of ALS patients and their totalquality of life.

It's time to stop saying “the mind is unaffected” in ALS

When Professor Stephen Hawking died in March 2018 after living with amyotrophic lateral sclerosis (ALS) for 55 years, the obituaries rightly celebrated a brilliant mind trapped in a failing body.

Cognitive impairment in amyotrophic lateral sclerosis: the hidden challenges

There is no cure for MND, with treatment limited to one drug, Riluzole, known to extend survival by only 2–3 months, and has been recommended by the National Institute of Health and Care Excellence (NICE, 2001).
...

References

SHOWING 1-10 OF 14 REFERENCES

Prevalence and patterns of cognitive impairment in sporadic ALS

These data confirm the presence of cognitive impairment in 50% of patients with ALS and particularly implicate executive dysfunction and mild memory decline in the disease process and have features consistent with FTD.

Frontotemporal white matter changes in amyotrophic lateral sclerosis

The hypothesis of a continuum of extra–motor cerebral and cognitive change in ALS patients with no evidence of cognitive change is supported, and structural white matter abnormalities in frontal and temporal regions revealed here may underlie the cognitive and functional imaging abnormalities previously reported in non–demented ALS patients.

Motor neurone disease, dementia and aphasia: coincidence, co-occurrence or continuum?

This review demonstrates that the association between MND and dementia was described and recognised as an entity as early as 1929, and its close relationship to Pick's disease was postulated in 1932.

Cognitive function in amyotrophic lateral sclerosis

Word retrieval in amyotrophic lateral sclerosis: a functional magnetic resonance imaging study.

Evidence of cerebral abnormalities in ALS in the network of regions involved in language and executive functions is provided, which further illustrates the heterogeneity of cognitive and cerebral change in ALS.

Prevalence of depression in a 12‐month consecutive sample of patients with ALS

Comparison of prevalence rates of depression and anxiety in ALS using different assessment tools found that the estimated prevalence of mood disorder amongst patients with ALS may vary significantly depending on the measure used.

Information-seeking behaviour among people with motor neurone disease.

  • M. O'brien
  • Psychology
    British journal of nursing
  • 2004
This qualitative study employed indepth, semistructured audiotaped interviews with seven people with motor neurone disease (MND) to explore their desire for information about MND and their

Clinical practice guideline on shared decision-making in the appropriate initiation of and withdrawal from dialysis

The Renal Physicians Association (RPA) and the American Society of Nephrology (ASN) in conjunction with representatives from multiple disciplines and organizations in the dialysis community, kidney

Involving Users in Shaping Motor Neurone Disease Services